Product Description
The XFT-2003EA H2 Hand Rehab System is a smart, wearable rehabilitation device designed to restore hand and wrist function for people recovering from stroke, hemiplegia, traumatic brain injury, incomplete spinal cord injury, or multiple sclerosis.
It combines surface EMG biofeedback with functional electrical stimulation (FES) to detect weak muscle signals and help the hand move naturally. The comfortable wristband design with built-in metal electrodes ensures easy wearing, stable contact, and consistent therapy. With multiple training modes and app-based control, it supports both clinical and home-based rehabilitation, helping users regain strength, control, and independence.
How does this XFT-2003EA hand rehab system work for recovery?
-
Activates weak hand muscles: When the user attempts to move their hand, the system detects the electrical signal (EMG) and then adds a gentle stimulation pulse to help the muscle contract. This supports improved movement even when strength is low.
-
Improves hand coordination and control: By combining voluntary effort, biofeedback and stimulation, users engage their hands actively during therapy rather than passive movement alone. This helps build better coordination, endurance and functional use.
-
Encourages neural reconnection: Repeated practice of hand movements with feedback and stimulation promotes new neural pathways and greater brain-muscle communication for long-term recovery.
-
Prevents muscle atrophy and joint stiffness: Keeping the hand active helps maintain muscle tone, joint mobility and circulation, reducing secondary complications.
-
Boosts engagement and motivation in therapy: The interactive training modes and game formats make therapy more engaging, encouraging consistent use and better outcomes.
-
Suitable for both clinical and home settings: The device’s wearable, user-friendly design allows patients to continue therapy outside of scheduled clinical visits, thereby increasing the volume and frequency of use.







Reviews
There are no reviews yet.